Premium
Impact of pay for performance on access at first dialysis in Queensland
Author(s) -
Haarsager Jennie,
Krishnasamy Rathika,
Gray Nicholas A
Publication year - 2018
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.13037
Subject(s) - medicine , dialysis , arteriovenous fistula , peritoneal dialysis , central venous catheter , hemodialysis , odds ratio , catheter , emergency medicine , surgery
Aim Commencement of haemodialysis with an arteriovenous fistula (AVF) or arteriovenous graft (AVG) is associated with improved survival compared with commencement with a central venous catheter. In 2011–2012, Queensland Health made incentive payments to renal units for early referred patients who commenced peritoneal dialysis (PD), or haemodialysis with an AVF/AVG. The aim of this study was to determine if pay for performance improved clinical care. Methods All patients who commenced dialysis in Australia between 2009 and 2014 and were registered with the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) were included. A multivariable regression model was used to compare rates of commencing dialysis with a PD catheter or permanent AVF/AVG during the pay‐for‐performance period (2011–2012) with periods prior (2009–2010) and after (2013–2014). Results A total of 10 858 early referred patients commenced dialysis during the study period, including 2058 in Queensland. In Queensland, PD as first modality increased with time ( P < 0.001) but there was no change in AVF/AVG rate at first haemodialysis ( P = 0.5). In a multivariate model using the pay‐for‐performance period as reference, the odds ratio for commencement with PD or haemodialysis with an AVF/AVG in Queensland was 1.02 (95% CI 0.81–1.29) in 2009–2010 and 1.28 (95% CI 1.01–1.61) in 2013–2014. There was no change for the rest of Australia (0.97 95% CI 0.87–1.09 in 2009–2010 and 1.00 95% CI 0.90–1.11 in 2013–14). Conclusion Pay for performance did not improve rates of commencement of dialysis with PD or an AVF/AVG during the payment period. A lag effect on clinical care may explain the improvement in later years.